Equities

Pharma Equity Group A/S

Pharma Equity Group A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)0.24
  • Today's Change-0.003 / -1.23%
  • Shares traded251.21k
  • 1 Year change-38.14%
  • Beta1.1207
Data delayed at least 15 minutes, as of Sep 20 2024 10:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pharma Equity Group A/S, formerly Blue Vision A/S, is a Denmark-based company. The Company's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to be the biopharmaceutical company that develops the local treatments for serious, acute and chronic inflammatory diseases. The Company's purpose is also to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.

  • Revenue in DKK (TTM)0.00
  • Net income in DKK-30.43m
  • Incorporated2002
  • Employees2.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Standard Supply AS449.23m291.52m142.09m--0.48740.48880.38370.31632.442.443.762.430.9485--14.09--72.48--90.61------76.41--31.09--0.0083--226.76--114,307.40------
Coeli Fastighet I AB13.01m4.30m150.70m--52.120.8741--11.584.304.3012.99256.250.0538--130.99--1.78--1.93------33.09------0.4225--------------
CNI Nordic 5 AB-65.77bn-65.77bn158.41m----0.8953----------437.84----------------------------0.00--------------
Hunter Group ASA56.66m46.65m164.13m3.002.600.87983.482.900.73350.99881.022.170.4892--47.1329,641,400.0040.275.5643.955.73----82.3351.74----0.0015--------23.38-85.37--
Seafire AB (publ)620.19m-45.38m174.71m305.00--0.38844.350.2817-1.61-1.6122.0115.960.68312.388.422,831,832.00-5.00-1.77-6.92-2.2044.5443.06-7.32-2.490.6489-1.030.270--17.5181.58-516.67--159.21--
Panostaja Oyj-745.94bn-745.94bn184.99m1.14k--0.8689----------0.5352----------0.1081--0.1859--70.30--0.13670.8187--0.466---1.27-5.97-397.93---7.85--
Skogsfond Baltikum AB (publ)3.46m26.82m200.45m1.0011.621.317.4757.98145.45145.4518.751,293.050.0113--2.345,256,989.008.76--8.83---76.51--775.65-----1.640.2608---16.38---39.66------
Latvian Forest Company AB11.18m-12.13m235.92m----0.9076--21.10-0.5114-0.51140.44149.900.0355--24.62---3.868.96-3.999.4073.2875.34-108.52271.03---0.72020.15560.00-26.484.95-78.95-28.2013.41--
Inderes Oyj-745.94bn-745.94bn239.81m117.00--4.44----------4.21----------------------------0.22--27.08---77.96------
Pharma Equity Group A/S0.00-30.43m248.58m2.00--9.60-----0.0291-0.02910.000.02530.00-------37.07-18.23-59.38-24.34-----------6.600.4535-------807.36------
KH Group Oyj2.78bn-69.72m266.01m891.00--0.50801.710.0956-0.1585-0.15666.431.211.032.3114.41301,675.80-4.231.35-7.301.5535.07---4.092.740.2132-0.6120.642838.36--145.52-84.00------
Case Group AB91.83m528.11k296.34m17.00725.011.31--3.230.01930.01935.7710.650.4249----7,757,389.000.2441--0.270--42.25--0.5744----1.140.1132--141.41--114.52------
Pohjanmaan Arvo Sijoitusosuuskunta102.84m13.50m310.17m5.0022.970.441122.393.022.222.2216.89115.460.1271--29.462,757,200.001.673.761.693.79----13.1319.9216.28--0.1209--6.71-18.20-48.442.6744.96--
Springvest Oyj41.28m8.09m313.77m9.0038.781.7638.447.600.19470.19470.99324.280.2097----614,821.104.112.324.192.3574.8668.2819.6011.91----0.00---0.148619.70-38.65------
Concejo AB (publ)368.82m7.04m333.67m205.0051.530.770714.620.90470.91220.912248.0060.980.5342.304.842,735,610.000.638-9.020.8395-12.5539.4828.521.19-39.421.66--0.0864--43.997.76108.61--94.57--
Data as of Sep 20 2024. Currency figures normalised to Pharma Equity Group A/S's reporting currency: Danish Krone DKK

Institutional shareholders

0.17%Per cent of shares held by top holders
HolderShares% Held
Danske Bank A/S (Investment Management)as of 30 Jun 20241.69m0.17%
Data from 31 Aug 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.